ANALYSIS ON DIRECT MEDICAL EXPENSES OF PATIENTS WITH PULMONARY TUBERCULOSIS IN CHINA- BASED ON THE CASE OF 17,000 PATIENTS IN WUHAN

Author(s)

Zhang F1, Shen LJ2, Liu Z1, Zhao K1, Liu YH1
1China National Health Development Research Center, National Health Commission (NHC), Beijing, China, 2Tsinghua University, Shenzhen, China

OBJECTIVES : To analyze on the direct medical expenses and its influencing factors of patients with pulmonary tuberculosis (TB) from 2011 to 2018 in Wuhan, and to provide references for improving the medical assistance policy in China.

METHODS : We studied on a total of 17,522 TB patients with 1,258,953 medical records in Wuhan province, and analyzed the different kinds of direct medical expenses and its influencing factors by descriptive statistics and quantitative methods such as ranksum test, multivariable linear regression and generalized estimated equation.

RESULTS : From 2011 to 2018, the average total direct medical expenses was 45731.45 yuan per TB patient in Wuhan province, 147.51 yuan per outpatient visit, and 8849.57 yuan per inpatient visit. And each patient cost 9607.01 yuan per year. The average reimbursement rate was 6.36% for outpatients and 67.56% for inpatients. The main population of TB patients were aged between 30-60 (49%), and most of the patients (73.71%) were covered by the Urban Employee Basic Medical Insurance (UEBMI), which had a higher reimbursement ratio compared to other medical insurance types. Factor analysis showed that the direct medical expenses were related to patients’ age, sex, year of visit, health care insurance type, medical institution levels and whether they had surgery and Chinese traditional medicine or not (P<0.01).

CONCLUSIONS : The current direct medical expenses of TB patients are relatively affordable, but for low-income patients and patients in severe condition, the financial burden is still heavy. Improved medical assistance policies are in need.

Conference/Value in Health Info

2019-11, ISPOR Europe 2019, Copenhagen, Denmark

Code

PIN61

Disease

Infectious Disease (non-vaccine)

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×